JANUMET XR (metformin hydrochloride; sitagliptin phosphate) Merck sharp dohme Patent: 6,699,871 Expiration: Jan 26, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are five…
Annual Drug Patent Expirations for JANUMET Janumet is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from two suppliers. There are four…
Annual Drug Patent Expirations for JANUVIA Januvia is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from three suppliers. There are three…
Annual Drug Patent Expirations for JUVISYNC Juvisync is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are four patents protecting this drug and three…
Annual Drug Patent Expirations for JANUMET+XR Janumet Xr is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are…
Annual Drug Patent Expirations for VIZAMYL Vizamyl is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. There are five patents…
LATISSE (bimatoprost) Allergan Patent: 8,758,733 Expiration: Jan 15, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit…
Annual Drug Patent Expirations for NOURIANZ Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from one supplier. There are four patents…
Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There are six patents protecting…
